South Korea Car-T Cell Therapy Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (undefined)

South Korea Car-T Cell Therapy Market is Segmented By Targeted Antigen (CD19, CD20, BCMA, GCP-3, Claudin 18.2), By Therapeutic Application (B-cell non-Hodgkin\'s lymphoma, Multiple Myeloma, Cervical Cancer, Gastric Cancer, Lung Cancer, Others). The report offers the value (in USD Million) for the above-mentioned segments

South Korea Car-T Cell Therapy Market Size

Market Size in USD

CAGR16.1%

Study Period2024 - 2031
Base Year of Estimation2023
CAGR16.1%
Market ConcentrationMedium
Major PlayersNovartis AG, Pfizer, Inc., Bristol Myers Squibb, CARsgen Therapeutics Co., Ltd., Fate Therapeutics, Inc.
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
setting-icon
Want to purchase customized report?
please let us know !

South Korea Car-T Cell Therapy Market Analysis

The South Korea Car-T Cell Therapy Market is estimated to be valued at USD 7.88 Mn in 2024 and is expected to reach USD 18.91 Mn by 2031, growing at a compound annual growth rate (CAGR) of 16.1% from 2024 to 2031.

With successful treatment of hematologic malignancies and rising investment by both public and private players in developing CAR-T therapies, the market is expected to witness steady growth.